Main market
Access this stock data via API
Subscribe
Genor Biopharma Holdings Limited
0
0
0%

Financials

Income statement

Fundamentals currency is CNY
Fiscal date 2024 2023 2022 2021
Total reported revenue 227.6M 0 17.4M 0
Cost of revenue 1.5M 0 1.1M 0
Gross profit 226.2M 0 16.3M 0
Operating expense
Research & development 223.8M 622.8M 637.9M 612.7M
Selling general and admin 79.1M 138.2M 237.4M 306.0M
Other operating expenses
Operating income -36.1M -757.0M -859.0M -918.7M
Non operating interest income
Income 36.1M 32.7M 30.7M 23.7M
Expense 123.6K 980.2K 3.1M 2.4M
Other income expense
Pretax income -38.8M -747.8M -800.2M -866.3M
Tax provision 19.7M -2.5M -2.2M -932K
Net income -58.5M -745.3M -798.0M -865.4M
Basic EPS -0.1 -1.3 -1.5 -1.8
Diluted EPS -0.1 -1.3 -1.5 -1.8
Basic average shares 566.8M 558.8M 551.0M 464.9M
Diluted average shares 566.8M 558.8M 551.0M 464.9M
EBITDA 16.5M -653.6M -738.5M -803.2M
Net income from continuing op. -38.8M -747.8M -800.2M -866.3M
Minority interests 1.7M 854K 182K 150K
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 3 hours 38 minutes

12:21
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
09:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 16:10
All times are displayed in the Asia/Hong_Kong timezone (HKT, UTC+08:00).